Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.

Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States. BMC Cardiovasc Disord. 2021 03 26; 21(1):155.

View in: PubMed

subject areas

Baroreflex
Chronic Disease
Cost Savings
Cost-Benefit Analysis
Electric Stimulation Therapy
Health Care Costs
Heart Failure
Humans
Models, Economic
Pressoreceptors
Time Factors
Treatment Outcome
United States

authors with profiles

Michael R. Zile